Is There a Best Ivermectin Dosage for Cancers or Different Cancer Types?

Executive Summary

• We sometimes receive questions about whether there is a best dosage of Ivermectin for different cancer types.
• I cover how we have adjusted our Ivermectin dosage calculator per different cancer types.

Introduction

The dosage of Ivermectin varies for different cancer types, which is one of the most common questions we receive at our subscription website. The high-level answer to this question is yes; it does make sense to adjust the dosage of ivermectin per cancer type.

The Flow of This Article

I will begin by discussing essential considerations when using Ivermectin, followed by an examination of the different dosage calculations for various cancer types, as well as the other inputs that we use to adjust our Ivermectin calculation estimate.

Things to Know About Ivermectin for Treating Cancer

The following items are important considerations to keep in mind when using Ivermectin for different cancer types.

Important Point #1: How Ivermectin Compares Against Other Non-Conventional Cancer Treatments

• Ivermectin is, in our view, the top non-standard or non-conventional drug for cancer. A close second would be Fenbendazole, which is also an anti-parasitic drug that works against cancer through different mechanisms than Ivermectin, as we cover in the article By How Many Different Mechanisms Does Fenbendazole Fight Cancer?

The Evidence for Ivermectin’s Effectiveness

• The evidence of the effectiveness of Ivermectin versus cancer is covered in many different articles on our site, which point out studies that you can find at our Ivermectin Article Index.
• Therefore, I won’t be covering the evidence for its effectiveness in this article.

Important Point #2: Ivermectin’s Use as Both a Treatment and Preventive

Ivermectin is very effective against cancer as a treatment, but also as a cancer-preventive.

• It can be taken without issue for long periods to both prevent cancer and minimize the recurrence of cancer.
• We have feedback from many subscribers, which you can read (see our Testimonials article) on the long-term use of Ivermectin.

Dosage Change for Treatment Versus Prevention

Our cancer dosage calculators include an adjustment for whether the drug is being taken as a treatment or as a preventative.

Ivermectin Safety

We are long-term users of Ivermectin ourselves at Brightwork Research. We have tested Ivermectin for years and found many of the claims against Ivermectin by the medical establishment to be false. The topic of safety is covered in detail in the article Answering the Question of Is Ivermectin Safe.

Important Point #3: Why Taking Ivermectin is a Much More Straightforward Decision Compared to the Decision to Use Conventional Cancer Treatments

Taking conventional cancer treatments should involve a detailed analysis of the usually complex treatment and its cost-benefit (the subscription site covers all the major traditional cancer treatments in detail).

• In a high percentage of cases, patients should consider alternative treatments to the conventional options they are being recommended. However, the vast majority of cancer patients never perform this analysis.
• The effectiveness level of conventional cancer treatments, in comparison to the money spent on developing and applying them, is poor and is not improving much — which you would never know from reading the cancer center websites or listening to oncologists. For example, chemotherapy adds a minimal amount to life expectancy, which I cover in the following article: Is Chemotherapy Treatment Worth Its Expected Life Extension?

Using Ivermectin Along With Conventional Cancer Treatments

• Even if one begins conventional cancer treatments, there is no reason that one cannot also take ivermectin, as it does not negatively affect other cancer treatments. There is no positive impact of chemotherapy. Secondly, as I cover in the article Using Ivermectin as a Backup to Conventional Cancer Treatment, it’s also a good idea to begin ivermectin if one has cancer because one may not be able to complete the conventional cancer treatments that they start.
• On the other hand, taking Ivermectin requires far less analysis as it provides additional health benefits and is something every cancer patient should be taking.

Important Point #4: How Ivermectin Compares Against Conventional Cancer Treatments for Side Effects

• As I cover in the articles Answering the Question of Is Ivermectin Safe and Answering the Question of the Side Effects of Ivermectin in Humans, Ivermectin has extremely low side effects compared to any conventional cancer treatment — while traditional cancer treatments are some of the highest side-effect drugs that exist in medicine. In many cases, the only way to get patients to accept conventional cancer treatments is to hide the actual predicted outcomes from the patient.

Being Both a Treatment and Preventive

• The cost of Ivermectin is significantly lower than that of conventional cancer treatments, and its benefits often surpass those of conventional treatments. This makes it a very easy choice. Furthermore, the low cost and ability to take Ivermectin long term make it worthwhile for prevention, which conventional cancer treatments are not.

Important Point #5: How The Medical Establishment Hides the Benefits of Ivermectin for Cancer

• There is realistically no way to get Ivermectin accepted by the medical establishment for cancer treatment because they already have established, very profitable lines of business such as chemotherapy, immunotherapy, etc. And this is how the major cancer centers make their money. Additionally, institutions such as universities, medical schools, and health authorities are aligned with cancer centers, pharmaceutical companies, and other relevant organizations. A significant thing that the cancer industry does is block the acceptance and use of cancer treatments that threaten the conventional cancer treatments. This same thing is done when the medical establishment discredits older, effective drugs that have come off patent and replaces them with new drugs that are on patent — a topic I cover in the article Drug Treadmill: How Drug Companies Perpetually Claim New Drugs Have Fewer Side Effects Than Older Drugs, and the article Analysis of The Deceptive Marketing of PPIs Like Nexium And Prilosec.
• This is why discussions regarding the use of Ivermectin for cancer with your oncologist regarding taking Ivermectin, or telling oncologists that you are taking Ivermectin, is counterproductive — which I cover in the article The Question of Finding an MD to Work With You on Ivermectin for Cancer and How Oncologists Provide False Information to Cancer Patients on Ivermectin and Fenbendazole.
• Luckily, taking Ivermectin does not interfere with conventional cancer treatments, as I cover in the article How Ivermectin Reduces Cancer Chemotherapy Resistance.

The Drug Company Strategy of Promoting New On Patent, Less Safe, and Less Effective Drugs Versus Drugs Which are Off Patent

The following quote is from the article Integrative Approaches For Cancer

Pierre Kory considers repurposed drugs to be the achilles heel of the pharmaceutical industry since the entire business depends upon selling incredibly expensive proprietary medicines under the justification it is immensely expensive to prove they are safe and effective—whereas in contrast no money can be made off the repurposed drugs (since their patents expired) which nonetheless must stay legal since they were previously proven to be safe and approved by the FDA.

Getting Into Ivermectin Dosage Calculation

Now that we have established the background and other important things to know regarding using Ivermectin in cancer treatment, let us now switch to the topic of Ivermectin dosage calculation for different cancer types.

Our Approach to Dosage Estimation Per Cancer Type

Important Item #1: How Studies Are Generally Designed Regarding Dosage

Studies typically do not test different dosage levels during the study, and the benefits associated with each dosage are then compared.

Therefore, the studies do not investigate multiple dosages of Ivermectin for pancreatic, colon, or lung cancer and then publish the results to determine which is best.

Instead, they typically will choose one dosage and then measure if there is an improvement in a cancer outcome. The state of current and previous Ivermectin studies is such that they test whether Ivermectin at a single selected dosage is beneficial.

Important Item #2: How We Use Many More Inputs Than Body Weight to Perform the Dosage Estimate

Virtually all ivermectin dose adjustments only use the individual weight as input to the estimate. This is an extremely oversimplified approach to setting dosage, as multiple factors influence the estimated doses, in addition to weight.

Medicine has a major problem with estimating dosages, which we cover in the article The Problem With Dosage Calculation in Medicine.

This topic applies to medical dosage estimation in general, and the majority of drugs are not adjusted for body weight. This is referred to as fixed weight dosing.

Consequently, people with dramatically different metabolisms and abilities to process drugs through their systems receive the same dosage. Once one analyzes how little thought goes into drug dosage estimation by the pharmaceutical companies, it is amazing to see MDs continue to keep patients on drugs that they are being overdosed on, with the MDs stating that that is the standard dose and should be adhered to.

This article Case Study: Ivermectin and Cervical Cancer, which is from one of our subscribers, illustrates a clear case of a patient being overdosed with a conventional cancer treatment.

Considering How MDs Are Incentivized

This topic raises questions about the ability of most medical doctors to act and think independently. All of the incentives are lined up to get MDs to follow the recommendation precisely, even if they see that a patient is being overdosed and their health is damaged.

An Overfocus on Calculation Errors Versus The Development of Dosage Standards

Generally, the focus of medicine on this topic is addressing medical errors in dosage calculation — that is, deviations from the standard formula. The topic I am bringing up is not even covered in articles — instead, all of the articles are about miscalculation, not about how the original formulas are developed. 

My point here is different, which is that far too little effort is invested in developing the standard formula during the clinical trial, combined with the standard formulas not being adjusted due to examples from the field, and the dosage not being adjusted according to the patient’s specific capacities and requirements.

Important Item #3: How We Adjust Our Calculator Per the Cancer Type

We have adjusted our cancer dosage estimation based on the time a person has to overcome the cancer or its risk to the patient, taking into account the cancer type. Some cancers provide the patient with less time to beat the cancer because there is a wide range in mortality rates for the different cancer types.

Important Item #4: How We Adjust Our Calculator for Cancer Progression or Stage

We have adjusted our cancer dosage estimation based on both the physical characteristics of the individual and the time a person has to overcome the cancer or its risk to the patient, taking into account both the cancer type and whether the cancer has metastasized.

And, of course, metastasis also means that the time to beat the cancer is shorter than it was before the metastasis occurred.

Important Item #5: How We Adjust Our Calculator for Treatment Versus Maintenance/Prevention

After a person has cancer or if they want to prevent cancer, the calculator adjusts the dosage to be lower than if they are currently treating cancer. Nearly all cancer centers do not provide any recommendations for how to prevent future cancers; however, it is very important for anybody who has gone through having cancer to do so.

Important Item #6: How These Adjustments Occur Within the Calculator

• We adjust the initial dosage calculation by considering factors that increase or decrease it.
• All of this happens within the calculator, so the user sees what our estimate is for their calculated dose.

Seeing a Sample Dosage Calculator

This is how we included a cancer-type adjustment into our Ivermectin cancer dosage calculator.

The Problem With Generally Available Ivermectin Dosages and Frequencies of Use

When provided by any website from a medical establishment, Ivermectin dosage information will be deliberately set too low and too infrequently. Many other sources will give a dosage for Ivermectin’s use that is not based on cancer studies at all, but rather the standard dose from Merck used when the drug is used to fight parasites.

That is for Ivermectin’s original use. The antiparasite dosage and frequency are not relevant for people looking for a dosage versus cancer.

Our cancer dosage calculators (one for pounds and one for kilograms) are specific to cancers and even adjust per cancer type, sex of the individual, cancer stage etc.

Conclusion

• We have developed an Ivermectin dosage calculator for cancer that adjusts the doses taken from all Ivermectin cancer studies for multiple factors, including the patient’s sex and cancer type.
• We have combined multiple factors, including studies on the use of Ivermectin in cancer treatment, anecdotal studies, and the aggressiveness of the cancer type, to develop our dosage calculator.
• Our calculator adjusts for cancer type.
• We have many articles that cover Ivermectin, which provide essential context that users of Ivermectin want to learn about from a vast majority of dimensions regarding effectiveness, safety, and use.
• This dosage calculator, along with the rest of the articles on our site, is available exclusively to subscribers. We offer the most extensive collection of articles on both Ivermectin and Ivermectin versus cancer at our subscription site.

About Our Ivermecting Testing Program and Recommended Ivermectin Source of Supply

• We performed pharmaceutical testing on Ivermectin to find a lower-cost version that also matched Merck's original Ivermectin in bioequivalence.
• You can read about the details of our Ivermectin testing in this article, Our Ivermectin Bioequivalence Testing.
• We got Summit Products to carry this version of Ivermectin, which passed our bioequivalence testing.